Zinc finger protein 793 (ZNF793)

Zinc finger protein 793 is a member of the large zinc finger (ZNF) protein family, which acts as a DNA-binding transcription factor, likely regulating gene expression by RNA polymerase II[6][7]. ZNF793 is a protein-coding gene in humans and encodes a protein of 406 amino acids[1][7]. Like other C2H2-type zinc finger proteins, it contains characteristic structural motifs coordinated by zinc ions, which allow it to interact with specific DNA sequences and modulate transcriptional activity[2][5][8]. While the precise biological function of ZNF793 itself is not fully characterized, members of this family play key roles in transcription regulation, cell differentiation, apoptosis, and other cellular processes[3][5][8]. ZNF793 has been implicated in Barrett's esophagus and lung non-small cell carcinoma, suggesting a potential involvement in cancer biology[7]. There is currently no evidence for direct therapeutic targeting, drug interactions, or relevant biomarkers for patient selection related to this protein. ZNF793 is predicted to exert its function in the nucleus as a sequence-specific DNA-binding transcription factor[6][7]. The family of zinc finger proteins is extremely diverse and abundant in the human genome, with substantial evidence of disease association, particularly in cancer, but most individual proteins remain poorly characterized at the clinical level[2][3][5][8]. No specific drugs or mechanism-of-action agents targeting ZNF793 are reported in current databases, and there are no widely recognized clinical biomarkers or safety concerns specific to this protein.

Other names

ZN793_HUMANZNF793